Title: Access to Best Practices for Co-Occurring Disorders: Research and Practice Partnerships
1Access to Best Practices for Co-Occurring
Disorders Research and Practice Partnerships
Constance Weisner, DrPH, MSWStacy Sterling, MSW,
MPHSujaya Parthasarathy, PhDJennifer Mertens,
MACharlie Moore, MD, MBA University of
California at San Francisco and Division of
Research, Northern California Kaiser
PermanenteConference on Complexities of
Co-Occurring Conditions Harnessing Services
Research to Improve Care for Mental Health,
Substance Use, and Medical/Physical Disorders,
June 24, 2004, Washington, DC
From studies funded by the National Institute on
Alcohol Abuse and Alcoholism, National Institute
on Drug Abuse, Center for Substance Abuse
Treatment, and Robert Wood Johnson Foundation
2Broadening the research focus in improving access
and utilization of best practices
- Asking new research questions
- develop questions in collaboration with
clinicians - Studying the implementation process
- the variety of stakeholders that influence
adoption of, and access to, best practices
3Sources of Research Questions Research
literature Policy issues Clinical concerns
Generates research intervention study
Intervention evaluated
- Health Plan
- Clinicians
- Program (CD MH)
- Primary Care
- Consumers
- Purchasers/employers
- Accreditation bodies
- Health policy
Program change implemented
Stakeholder concerns shape implementation
Sterling Weisner, (2002) Closing the Loop A
Model to Address the Transfer of Research to
Practice
4OVERVIEW
- Importance of access
- Screening, assessment, and integrated
services - Conceptual model and application
5Research Supporting Integrated Services
- Assessment Many individuals entering CD and MH
treatment have co-occurring problems.
(Rounds-Bryant et al., Grella et al. 2001 Rao,
2000 Greenbaum et al., 1996) - Screening These co-occurring problems could be
identified earlier before they are severe. (Samet
et al., 2001) - Integrating services Providing services that
address those problems is related to outcomes.
(McLellan et al., 1998, 1993 Willenbring
Olson, 1999)
6Setting
Kaiser Permanente Medical Care Programof
Northern California
Sacramento
- Non-profit, group practice prepaid HMO
- 3.2 million members (35 of commercially insured
population) - Carved-in psychiatry and chemical dependency
services
7Adolescent Chemical Dependency Treatment Sample
- 419 adolescents (143 girls, 276 boys) and parents
- 4 facilities
- Age ranged from 13 to 18 years
- Ethnicity 9 Native American/Asian
- 16 African-American
- 20 Hispanic
- 49 White
- Treatment intake, 6-month, and 1-, 3-, 5 years
- Response rate 6-month 91.4 1-year 92.1
8Psychiatric Conditions of Adolescents Entering
CD Treatment (in )
Intakes (419) MatchedControls (2007) p-value
Depression 24.0 0.3 lt.0001
Conduct Disorder with ODD 17.0 0.2 lt.0001
Conduct Disorder 11.0 0.2 lt.0001
ADHD 10.0 0.7 lt.0001
Anxiety 6.4 0.3 lt.0001
Eating Disorders 1.2 0.1 lt.01
1 Psychiatric Conditions 37.0 2.0 lt.0001
9ARE PSYCHIATRIC SERVICES RELATED TO OUTCOME?
10Role of Dual Treatment Logistic Regression
Predicting Abstinence at 6 Months
- Receiving mental health services while in
chemical dependency services was related to
better alcohol and drug outcomes at 6 months.
11An Adult Example 5-Year Abstinence when
Psychiatric Services Provided
- For those who still had psychiatric problems at
12 month follow-up - 2 or more hours/year over the 5 years
- O.R. 5.5
-
- Plt.05
- Controlling for age, gender, type of
dependence, abstinence goal, readmission, of
12-step meetings, recovery-oriented social
support, treatment intensity
12Are Medical Services Related to Outcome?
13An Adult Example CD Patients and Matched
Health Plan Members Medical Conditions
CD Patients (N747) Matched Members (N3,690)
Injury and Overdoses 25.6 12.1
Lower Back Pain 11.2 5.8
Headache 9.2 3.8
Hypertension 7.2 3.4
Asthma 6.8 2.6
Acid-related Disorders 5.5 2.1
Arthritis 3.9 1.3
all plt.001
Mertens, Lu, Parthasarathy, Moore, Weisner.
(2003). Medical and psychiatric conditions of
alcohol and drug treatment patients in an HMO
Comparison to matched controls. Archives of
Internal Medicine.
14Randomized Adult SAMC Group Logistic Regression
Predicting Abstinence at 6 Months
Independent Variable O.R. 95 C.I.
Integrated Care (vs. Usual Care) 1.90 (1.22, 2.96)
Controlling for baseline alcohol and drug severity
- Weisner C, Mertens J, Parthsarathy S, Moore C, Lu
Y. (2001). Integrating primary medical care with
addiction treatment A randomized controlled
trial. JAMA 286(14)1715-1723.
15Medical Costs 12 Months after Treatment for
Randomized CD Patients with Psychiatric Medical
Conditions
plt.05 plt.01
Parthasarathy S, Mertens J, Moore C, Weisner C.
(2003). The utilization and cost impact of
integrating substance abuse treatment and primary
care. Medical Care.
16Sources of Research Questions Research
literature Policy issues Clinical concerns
Generates research intervention study
Intervention evaluated
- Health Plan
- Clinicians
- Program (CD MH)
- Primary Care
- Consumers
- Purchasers/employers
- Accreditation bodies
- Health policy
Program change implemented
Stakeholder concerns shape implementation
Sterling Weisner, (2002)Closing the Loop A
Model to Address the Transfer of Research to
Practice
17 Research Practice Model
- CD MH Directors/Chiefs Groups
- Business case outcomes cost
- Parity legislation
- Identifying next generation of research questions
- Survey of pediatricians
- Clinicians
- Development of assessment for MH and CD clinics
- PC ER physicians
- Results to their professional organizations
- Identifying next generation of research questions
- Assessment in MH and CD clinics
- Readiness to change AOD use in MH clinics
- Dual Diagnosis Best Practice Committee
- Concept development of liaison model
- Core competencies, care guidelines
- Training
- Identifying next generation of research questions
18Conclusions
- A wide variety of stakeholders influence access
- Demonstrating both outcome and cost is important
in improving access - Integrating research and practice can lead to
better understanding how to study and address
access
19COLLABORATORS
- Felicia Chi, MPH
- Steve Allen, PhD
- David Pating, MD
- Bill Brostoff, MD
- Christine Waters, MD
- Agatha Hinman, BA
- Georgina Berrios, BA
- Tom Ray, M.A.
- Wendy Lu, MPH
- Cynthia Campbell, PhD
- Derek Satre, PhD
- Carolynn Kohn, PhD
- Melanie Jackson, BA
- Cynthia Perry-Baker, BA
- Lynda Tish, BA
- Barbara Picchoto, BA
- Kaiser Permanente Clinics
- Oakland
- Sacramento
- San Francisco
- Stockton
- Vacaville
- Vallejo